1.
Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet.2017;390(10089):73-84. doi:10.1016/s0140-6736(16)31591-4
2.
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosingspondylitis: an overview. Ann Rheum Dis. 2002;61 Suppl 3(Suppl3):iii8-18. doi:10.1136/ard.61.suppl_3.iii8
3.
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P,Calin A. A new approach to defining disease status in ankylosingspondylitis: the bath ankylosing spondylitis disease activity index.J Rheumatol. 1994;21(12):2286-2291.
4.
Bas DB, Su J, Wigerblad G, Svensson CI. Pain in rheumatoidarthritis: models and mechanisms. Pain Manag. 2016;6(3):265-284. doi:10.2217/pmt.16.4
5.
Loeser JD, Treede RD. The Kyoto protocol of IASP basic painterminology. Pain. 2008;137(3):473-477. doi:10.1016/j.pain.2008.04.025
6.
Kieskamp SC, Paap D, Carbo MJG, et al. Central sensitization,illness perception and obesity should be considered wheninterpreting disease activity in axial spondyloarthritis.Rheumatology (Oxford). 2021;60(10):4476-4485. doi:10.1093/rheumatology/keab019
7.
Arends S, Brouwer E, Efde M, et al. Long-term drug survivaland clinical effectiveness of etanercept treatment in patientswith ankylosing spondylitis in daily clinical practice. Clin ExpRheumatol. 2017;35(1):61-68.
8.
Baskan E, Yagci N, Cavlak U. Factors affecting body awarenessin older adults with chronic musculoskeletal pain. Arch Med Sci.2021;17(4):934-939. doi:10.5114/aoms.2019.86614
9.
Kalkışım ŞN, Erden A, Kanber Uzun Ö, Ertemoğlu Öksüz C,Zihni NB, Çan MA. Relationship between body awarenesslevel and musculoskeletal pain complaints, physical activitylevel and emotional status in healthy people. Acta Neurol Belg.2023;123:1789-1796. doi:10.1007/s13760-022-02056-2
10.
Baas LS, Beery TA, Allen G, Wizer M, Wagoner LE. Anexploratory study of body awareness in persons with heart failuretreated medically or with transplantation. J Cardiovasc Nurs.2004;19(1):32-40. doi:10.1097/00005082-200401000-00007
11.
Bekker MH, Croon MA, Van Balkom EG, Vermee JB. Predictingindividual differences in autonomy-connectedness: the role ofbody awareness, alexithymia, and assertiveness. J Clin Psychol.2008;64(6):747-765. doi:10.1002/jclp.20486
12.
Durlik C, Cardini F, Tsakiris M. Being watched: the effect of socialself-focus on interoceptive and exteroceptive somatosensoryperception. Conscious Cogn. 2014;25:42-50. doi:10.1016/j.concog.2014.01.010
13.
Gyllensten AL, Hui-Chan CW, Tsang WW. Stability limits, single-leg jump, and body awareness in older Tai Chi practitioners.Arch Phys Med Rehabil. 2010;91(2):215-20. doi:10.1016/j.apmr.2009.10.009
14.
Erden A, Altuğ F, Cavlak U. Investigation of the relationshipbetween body awareness, pain, emotional status, and quality of lifeamong healthy people. J Kartal Train Res Hosp. 2013;24(3):145-150.
15.
Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I.Imaging how attention modulates pain in humans using functionalMRI. Brain. 2002;125(Pt 2):310-319. doi:10.1093/brain/awf022
16.
Johnson MH. How does distraction work in the managementof pain? Curr Pain Headache Rep. 2005;9(2):90-95. doi:10.1007/s11916-005-0044-1
17.
Burns JW. The role of attentional strategies in moderating linksbetween acute pain induction and subsequent psychological stress:evidence for symptom-specific reactivity among patients withchronic pain versus healthy nonpatients. Emotion. 2006;6(2):180-192. doi:10.1037/1528-3542.6.2.180
18.
Gard G. Body awareness therapy for patients with fibromyalgiaand chronic pain. Disabil Rehabil. 2005;27(12):725-728.doi:10.1080/09638280400009071
19.
Rudwaleit M, van der Heijde D, Landewé R, et al. Thedevelopment of Assessment of SpondyloArthritis internationalSociety classification criteria for axial spondyloarthritis (part II):validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi:10.1136/ard.2009.108233
20.
Hawker GA, Mian S, Kendzerska T, French M. Measures of adultpain: Visual Analog Scale for Pain (VAS Pain), Numeric RatingScale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ),Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic PainGrade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36BPS), and Measure of Intermittent and Constant OsteoarthritisPain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl11:S240-252. doi:10.1002/acr.20543
21.
Mayer TG, Neblett R, Cohen H, et al. The development andpsychometric validation of the central sensitization inventory. PainPract. 2012;12(4):276-285. doi:10.1111/j.1533-2500.2011.00493.x
22.
Düzce Keleş E, Birtane M, Ekuklu G, et al. Validity andreliability of the Turkish version of the central sensitizationinventory. Arch Rheumatol. 2021;36(4):518-526. doi:10.46497/ArchRheumatol.2022.8665
23.
Karaca S, Bayar B. Turkish version of body awarenessquestionnaire: validity and reliability study. Turk J PhysiotherRehabil. 2021;32(1):44-50.
24.
Mukaka MM. Statistics corner: A guide to appropriate useof correlation coefficient in medical research. Malawi Med J.2012;24(3):69-71.
25.
Hider S, Wong M, Ortiz M, Dulku A, Mulherin D. Does a regularexercise program for ankylosing spondylitis influence bodyimage? Scand J Rheumatol. 2002;31(3):168-171.
26.
Buke M, Cetisli-Korkmaz N, Basakci-Calik B, Karasu U. TheAssociation of Physical Activity Level with Body Awareness andBalance in Individuals with Ankylosing Spondylitis. AktuelleRheumatol. 2023. doi:10.1055/a-2085-2204.
27.
Ward MM. Health-related quality of life in ankylosing spondylitis:a survey of 175 patients. Arthritis Care Res. 1999;12(4):247-255.
28.
Karaca N, Kinikli G, Sezer S, Keleşoğlu B, Kinikli G. POS1589-HPR High disease activity has a negative effect on paincatastrophizing, fear avoidance and body awareness levels inpatients with ankylosing spondylitis—a preliminary study. AnnRheum Dis. 2023;82:1170.
29.
Guler MA, Celik OF, Ayhan FF. The important role of centralsensitization in chronic musculoskeletal pain seen in differentrheumatic diseases. Clin Rheumatol. 2020;39(1):269-274.doi:10.1007/s10067-019-04749-1
30.
Aykurt Karlıbel I, Kasapoğlu Aksoy M. The relationship betweencentral sensitization and disease activity, quality of life, and sleepquality among patients with axial spondyloarthritis. Ir J Med Sci.2023;192(1):481-489. doi:10.1007/s11845-022-02957-4
31.
Sariyildiz A, Coskun Benlidayi I, Turk I, Zengin Acemoglu SS, UnalI. Biopsychosocial factors should be considered when evaluatingcentral sensitization in axial spondyloarthritis. Rheumatol Int.2023;43(5):923-932. doi:10.1007/s00296-023-05317-2
32.
Kieskamp SC, Paap D, Carbo MJG, et al. Central sensitizationhas major impact on quality of life in patients with axialspondyloarthritis. Semin Arthritis Rheum. 2022;52:151933.doi:10.1016/j.semarthrit.2021.11.006